Article Information
History
- September 8, 2021.
Article Versions
- Version 1 (August 31, 2021 - 11:32).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yueh-Ming Loo1,
- Patrick M. McTamney1,
- Rosalinda H. Arends2,
- Robert A. Gasser Jr3,
- Michael E. Abram4,
- Anastasia Aksyuk4,
- Seme Diallo1,
- Daniel J. Flores1,
- Elizabeth J. Kelly4,
- Kuishu Ren1,
- Richard Roque1,
- Kim Rosenthal1,
- Katie Streicher4,
- Kevin M. Tuffy4,
- Nicholas J. Bond5,
- Owen Cornwell5,*,
- Jerome Bouquet6,
- Lily I. Cheng7,
- James Dunyak8,†,
- Yue Huang6,
- Anton I. Rosenbaum6,
- Hanne Andersen9,
- Robert H. Carnahan10,11,
- James E. Crowe Jr10,11,12,
- Ana I. Kuehne13,
- Andrew S. Herbert13,
- John M. Dye13,
- Helen Bright1,‡,
- Nicole L. Kallewaard1,§,
- Menelas N. Pangalos14 and
- Mark T. Esser15,#
- 1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
- 2Clinical Pharmacology and Quantitative Pharmacology, Microbial Sciences, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
- 3Clinical Development, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
- 4Translational Medicine, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
- 5Analytical Sciences, BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge, UK
- 6Integrated Bioanalysis, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, San Francisco, CA, USA
- 7Oncology Safety Pathology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
- 8Clinical Pharmacology and Pharmacometrics, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
- 9BIOQUAL Inc., Rockville, MD, USA
- 10Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
- 11The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA
- 12Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN, USA
- 13USAMRIID, Fort Detrick, MD, USA
- 14BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 15Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
- ↵#Corresponding author: Mark T. Esser, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA, Email: mark.esser{at}astrazeneca.com, Tel: 301.398.6849